
Santen Pharmaceutical Co. Ltd.
SNPHY | OTC
$11.23
+$0.45 (+4.17%)
At close: Oct 30, 2026, 3:15 PM ET
$11.23
$0.00 (0.00%)
After-hours:
Oct 30, 2026, 4:00 PM ET
Fiscal Quarter Period Ending | Q1 2027 Jun 30, 2026 | Q4 2026 Mar 31, 2026 | Q3 2026 Dec 31, 2025 | Q2 2026 Sep 30, 2025 | Q1 2026 Jun 30, 2025 | Q4 2025 Mar 31, 2025 | Q3 2025 Dec 31, 2024 | Q2 2025 Sep 30, 2024 | Q1 2025 Jun 30, 2024 | Q4 2024 Mar 31, 2024 | Q3 2024 Dec 31, 2023 | Q2 2024 Sep 30, 2023 | Q1 2024 Jun 30, 2023 | Q4 2023 Mar 31, 2023 | Q3 2023 Dec 31, 2022 | Q2 2023 Sep 30, 2022 | Q1 2023 Jun 30, 2022 | Q4 2022 Mar 31, 2022 | Q3 2022 Dec 31, 2021 | Q2 2022 Sep 30, 2021 | Q1 2022 Jun 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 68.96B | 80.86B | 72.88B | 69.14B | 68.74B | 77.23B | 76.37B | 71.63B | 74.77B | 79.13B | 77.03B | 73.42B | 72.39B | 79.25B | 70.87B | 63.38B | 65.53B | 70.46B | 67.04B | 63.77B | 64.99B |
Cost of Revenue | 31.27B | 31.19B | 34.34B | 31.33B | 33.8B | 33.51B | 36.27B | 33.57B | 34.44B | 34.04B | 34.53B | 31.8B | 32.35B | 29.79B | 31.61B | 30.11B | 30.96B | 29.45B | 32.31B | 28.31B | 28.96B |
Gross Profit | 37.69B | 49.67B | 38.54B | 37.81B | 34.94B | 43.72B | 40.1B | 38.06B | 40.33B | 45.09B | 42.5B | 41.62B | 40.04B | 49.46B | 39.26B | 33.27B | 34.57B | 41.01B | 34.74B | 35.46B | 36.02B |
Operating Income | 8.06B | 17.07B | 10.28B | 10.34B | 7.53B | 13.13B | 11.78B | 11.78B | 13.45B | 11.1B | 15.18B | 13.35B | 12.67B | 12.09B | 8.64B | 3.24B | 8.05B | 9.26B | 7.6B | 10.04B | 9.45B |
Interest Income | 957M | 300M | 455M | 257M | 627M | 2.57B | 421M | 306M | 702M | 259M | 486M | 152M | 1.05B | 159M | 428M | 128M | 1.39B | 1.33B | 540M | 82M | 590M |
Pretax Income | 8.34B | 19.37B | 10.44B | 10.18B | 7.45B | 12.17B | 11.47B | 10.39B | 13.45B | -3.69B | 9.48B | 11.21B | 12.87B | 5.79B | 7.51B | -28.18B | 9.07B | 9.94B | 7.28B | 9.22B | 9.55B |
Net Income | 7.19B | 15.55B | 7.88B | 8.06B | 5.88B | 8.79B | 8.69B | 8.14B | 10.63B | 30M | 7.33B | 8.87B | 10.41B | 1.12B | 5.98B | -28.7B | 6.66B | 7.87B | 5.04B | 6.97B | 7.38B |
Selling & General & Admin | 23.38B | 24.79B | 22.27B | 21.31B | 21.2B | 23.27B | 22.49B | 20.84B | 21.38B | 26.78B | 21.58B | 22.11B | 21.07B | 30.76B | 23.21B | 22.87B | 19.43B | 24.18B | 20.67B | 19.21B | 20.45B |
Research & Development | 6.25B | 7.81B | 6B | 6.16B | 6.21B | 7.33B | 5.83B | 5.44B | 5.5B | 7.21B | 5.75B | 6.16B | 6.3B | 6.62B | 7.42B | 7.17B | 7.1B | 7.57B | 6.46B | 6.22B | 6.12B |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 29.63B | 32.6B | 28.27B | 27.48B | 27.41B | 30.6B | 28.32B | 26.28B | 26.88B | 33.99B | 27.32B | 28.27B | 27.37B | 37.37B | 30.62B | 30.04B | 26.53B | 31.75B | 27.14B | 25.42B | 26.57B |
Interest Expense | 738M | 512M | 318M | 415M | 749M | 1.4B | 273M | 636M | 407M | 1.68B | 703M | 486M | 168M | 790M | 1.13B | 408M | 123M | 475M | 293M | 163M | 277M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 60.9B | 63.79B | 62.61B | 58.81B | 61.21B | 64.1B | 64.59B | 59.85B | 61.32B | 68.03B | 61.85B | 60.07B | 59.72B | 67.16B | 62.23B | 60.14B | 57.49B | 61.2B | 59.44B | 53.73B | 55.53B |
Income Tax Expense | 1.14B | 3.8B | 2.3B | 2.19B | 1.59B | 3.67B | 2.83B | 2.29B | 2.84B | -3.81B | 2.18B | 2.34B | 2.46B | 4.69B | 1.58B | 538M | 2.38B | 2.05B | 2.24B | 2.29B | 2.19B |
Shares Outstanding (Basic) | 321.34M | 325.02M | 322.72M | 329.97M | 339.17M | 341.36M | 343.09M | 349.49M | 359.15M | 363.21M | 353.63M | 360.45M | 372.78M | 377.03M | 385.52M | 379.87M | 396.75M | 400.27M | 399.77M | 399.73M | 399.63M |
Shares Outstanding (Diluted) | 322.6M | 325.72M | 323.64M | 330.15M | 340.16M | 341.72M | 344.41M | 350.22M | 360.44M | 363.21M | 354.92M | 361.6M | 373.98M | 377.03M | 386.55M | 379.87M | 397.31M | 400.55M | 400.54M | 400.48M | 400.42M |
EPS (Basic) | 22.39 | 47.85 | 24.42 | 24.43 | 17.33 | 25.73 | 25.34 | 23.29 | 29.61 | 0.08 | 20.73 | 24.60 | 27.93 | 2.96 | 15.49 | -75.56 | 16.78 | 19.66 | 12.60 | 17.42 | 18.47 |
EPS (Diluted) | 22.30 | 47.75 | 24.35 | 24.42 | 17.28 | 25.70 | 25.24 | 23.24 | 29.50 | 0.08 | 20.66 | 24.52 | 27.85 | 2.96 | 15.46 | -75.56 | 16.77 | 19.65 | 12.59 | 17.39 | 18.44 |
EBITDA | 12.78B | 24.43B | 15.38B | 15.29B | 12.7B | 17.97B | 16.25B | 15.36B | 18.56B | 2.56B | 14.87B | 16.6B | 17.07B | 10.69B | 12.76B | -23.22B | 13.67B | 14.93B | 11.81B | 13.87B | 13.64B |
EBIT | 8.06B | 19.88B | 10.76B | 10.6B | 8.2B | 13.57B | 11.74B | 11.03B | 13.86B | -2B | 10.19B | 11.69B | 13.04B | 6.58B | 8.63B | -27.77B | 9.2B | 10.42B | 7.57B | 9.39B | 9.83B |
Depreciation & Amortization | 4.72B | 4.55B | 4.62B | 4.69B | 4.5B | 4.4B | 4.51B | 4.34B | 4.71B | 4.56B | 4.69B | 4.9B | 4.03B | 4.1B | 4.13B | 4.55B | 4.47B | 4.51B | 4.24B | 4.49B | 3.81B |
Add to Watchlist
Select watchlists to add or remove SNPHY